ArticleMethods in molecular biology (Clifton, N.J.)2027
Global Identification of RNA Helicase Substrates from Large Nucleic Acid Sequence Libraries Using Helicase-SELEX.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In many instances, the RNA sequences or motifs that constitute optimal or physiological substrates for a given RNA helicase are unknown or difficult to identify. In this chapter, we describe a recent methodology, Helicase-induced Selection of Ligands by Exponential enrichment (Helicase-SELEX), which allows the global identification of catalytically productive substrates for a RNA helicase from a large library of nucleic acid sequences. We explain how to use the methodology to identify Rut (Rho utilization) sequences in bacterial genomes, which likely encode the physiological RNA targets used by the transcription termination factor Rho helicase. We discuss the advantages and limitations of the Helicase-SELEX methodology, including which categories of helicases are, in principle, the most amenable to Helicase-SELEX analysis.
Indexed as
Identifiers
42862229What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.